GlassScriptPhysician profile
Craig D Peppler
NPI 1518908904
$5,194.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $4,035 · 2021: $309 · 2022: $54.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,609.24 | 2019-2021 | |
| Horizon Therapeutics Plc | $1,500.00 | 2020 | |
| Sentynl Therapeutics, INC. | $263.26 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $222.36 | 2019-2022 | |
| Flowonix Medical Incorporated | $143.15 | 2019 | |
| Pfizer INC. | $113.57 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.98 | 2019-2020 | |
| Mdd US Operations, LLC | $80.09 | 2019-2020 | |
| Zyla Life Sciences, INC. | $46.92 | 2019 | |
| Collegium Pharmaceutical, INC. | $42.94 | 2019-2020 | |
| Boston Scientific Corporation | $38.85 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $17.73 | 2019 | |
| Daiichi Sankyo INC. | $12.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Peppler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.